SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is currently trending as speculation intensifies regarding its role in potential major oncology acquisitions, with community members actively debating its prospects as a suitor for companies like Sellas Life Sciences and Inhibrx. Investors are closely tracking these rumors against the backdrop of Merck's strategic need to bolster its pipeline to mitigate the impending impact of the patent cliff on its blockbuster franchise, Keytruda.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is facing intense volatility and community concern following the discovery of a critical vulnerability in its privacy protocol that theoretically allowed for unauthorized coin issuance. While the team has released a patch and disputes that any exploitation occurred, investors are deeply divided as the lack of transaction transparency creates uncertainty regarding the total circulating supply.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is currently in the spotlight as investors debate the company's turnaround potential, with the community closely tracking recent large-scale stock purchases by its CEO and increased institutional accumulation ahead of upcoming earnings. While bullish sentiment is fueled by the company's enterprise AI focus and aggressive restructuring efforts, skeptical traders remain vocal about historical revenue challenges and the stock's significant short interest, leading to intense speculation regarding a potential short squeeze.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

Lighter is capturing significant community attention following a major tokenomics overhaul that features a substantial permanent token burn and strategic buybacks funded by exchange revenue. Investors are actively discussing its integration with Robinhood's ecosystem and its competitive potential against other perpetual decentralized exchanges as it sees a surge in trading volume.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is currently trending as the community debates its long-term potential amid a recent security incident involving a protocol hack and persistent price volatility. Investors remain divided between bullish long-term supporters focused on enterprise adoption and institutional utility, and bearish voices concerned about tokenomics, dilution, and the asset's underperformance relative to historical price levels.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors debate the impact of its recent equity raise while anticipating the upcoming IZAR-1 Phase 3 readout. The community is focused on the potential for a multibillion-dollar buyout, with many market participants viewing the current price as an accumulation opportunity ahead of imminent clinical catalysts.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending as investors weigh its status as a high-quality global payment compounder against regulatory concerns, specifically proposed caps on credit card interest rates. Community discussions are centered on the stock's long-term moat, its integration of stablecoin and AI payment infrastructure, and whether current market volatility creates an attractive entry point for a durable cash-flow engine.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson remains a focal point for institutional investors due to its defensive stability and strong pharma pipeline, with market participants closely monitoring potential M&A activity and the impact of ongoing talc-related litigation. The stock continues to be a core holding for those seeking reliable growth and consistent dividend returns amid broader market rotation into healthcare.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing significant downward pressure and intense community frustration, with many investors debating whether current price levels represent a deep-value accumulation opportunity or a signal of structural failure. Despite ongoing institutional use cases and infrastructure milestones, the sentiment is heavily weighed down by lagging price action compared to other digital assets, leading to aggressive speculation about further downside risk.

SPX6900 is an advanced blockchain cryptography token coin capable of limitless possibilities and scientific utilization.

SPX6900

SPX6900 continues to trend as a community-driven "pure belief" asset, with followers frequently comparing its trajectory and cult-like devotion to the early days of Bitcoin or GameStop. The community remains hyper-focused on DCA strategies and social mobilization, positioning the token as a rebellious alternative to traditional equity markets while actively ignoring broader volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Want Steady Retirement Income? Add This ETF to Your Portfolio and Do Nothing Else

Key PointsThe JPMorgan Equity Premium Income ETF uses a covered call strategy to generate income...

The Most Dangerous Dividend ETF Investors Keep Buying

Key PointsThe JPMorgan Equity Premium Income ETF came to prominence during the 2022 bear market, when it beat the S&P 500 by 15 percentage points...

Notable ETF Outflow Detected - JEPI, EOG, ETN, VRTX

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the JPMorgan Equity Premium Income ETF (Symbol: JEPI) where we have detected an approximate $456.1 million dollar outflow -- that's a 1.0% decrease week...

Retirees: Here's Why HDV Makes More Sense Than JEPI for Your Income Portfolio

Key PointsThe JPMorgan Equity Premium Income ETF (JEPI) built its reputation on a strong year in 2022...

The JPMorgan Equity Premium Income ETF Doesn't Interest Me, but It Might Work for You

Key PointsEquity and index options are speculative instruments that can produce surprisingly big returns...

Why JPMorgan Equity Premium Income ETF Limits Upside While JPMorgan Nasdaq Equity Premium Income ETF Sacrifices Growth for 11.98% Yields

Why JPMorgan Equity Premium Income ETF Limits Upside While JPMorgan Nasdaq Equity Premium Income ETF Sacrifices Growth for 11.98% Yields...

Notable ETF Inflow Detected - JEPI, ROST, ETN, NEE

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the JPMorgan Equity Premium Income ETF (Symbol: JEPI) where we have detected an approximate $400.3 million dollar inflow -- that's a 0.9% increase week o...

This High-Yield ETF Could Be Perfect for Income-Focused Investors

Key PointsThe JPMorgan Equity Premium Income ETF (JEPI) writes S&P 500 covered calls on top of a portfolio of low volatility equities...

The JPMorgan Equity Premium Income ETF (JEPI) and the JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Have a Glaring Flaw. Here's Why They Could Still Be Buys.

Key PointsCovered call ETFs are ideally suited for investors seeking monthly passive income rather than potential long-term gains...

Vanguard Dividend ETF quietly outperforms amid market panic

If you have been checking your portfolio every morning this year, you already know the tension. The S&P 500 has gone practically nowhere; the biggest tech names have pulled back. Tariff headlines...

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Says CEO Dimon ‘Fraudulently’ Included In Trump’s $5B Lawsuit, Seeks To Move Jurisdiction

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$56.76
Prev Close	$56.63
Open	$56.70
Dividend Yield	N/A
50-Day Moving Average	$56.17
Beta	N/A
Avg. Volume	5.11M
PE Ratio	N/A

52-Week High	$59.90
52-Week Low	$55.10
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

JEPIJPMorgan Equity Premium Income ETF

Latest JEPI News